Century Enka Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 12, 2025, 12:01 pm

Quick Insight

Century Enka Ltd, operating within the textiles sector, currently trades at ₹513 with a market capitalization of ₹1,121 crore. The company's price-to-earnings ratio stands at 19.0, suggesting a moderate valuation relative to its earnings. However, with a return on equity (ROE) of just 4.24% and a return on capital employed (ROCE) of 5.98%, profitability metrics indicate room for improvement. Despite a low operating profit margin (OPM) of 1.98%, the company's interest coverage ratio (ICR) of 21.73x signals robust financial health, given minimal borrowings of ₹37 crore against reserves of ₹1,400 crore. With 62.10% of shares held by the public and a price-to-book value (P/BV) ratio of 0.64x, Century Enka presents an undervalued opportunity, albeit with cautious attention to its operational efficiency. Investors should monitor management's strategies to enhance profitability as a key driver of future growth.

Competitors of Century Enka Ltd

All Competitor Stocks of Century Enka Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:50 pm

Below is a detailed analysis of the quarterly data for Century Enka Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 402.00 Cr.. The value appears to be declining and may need further review. It has decreased from 444.00 Cr. (Mar 2025) to 402.00 Cr., marking a decrease of 42.00 Cr..
• For Expenses, as of Jun 2025, the value is 382.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 435.00 Cr. (Mar 2025) to 382.00 Cr., marking a decrease of 53.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 11.00 Cr..
• For OPM %, as of Jun 2025, the value is 5.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Mar 2025) to 5.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 10.00 Cr..
• For Tax %, as of Jun 2025, the value is 19.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 19.00%, marking a decrease of 8.00%.
• For Net Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.02. The value appears strong and on an upward trend. It has increased from 3.16 (Mar 2025) to 7.02, marking an increase of 3.86.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 7:00 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:42 pm

Below is a detailed analysis of the balance sheet data for Century Enka Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 22.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,400.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,346.00 Cr. (Mar 2024) to 1,400.00 Cr., marking an increase of 54.00 Cr..
• For Borrowings, as of Mar 2025, the value is 37.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 52.00 Cr. (Mar 2024) to 37.00 Cr., marking a decrease of 15.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 327.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 268.00 Cr. (Mar 2024) to 327.00 Cr., marking an increase of 59.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,786.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,688.00 Cr. (Mar 2024) to 1,786.00 Cr., marking an increase of 98.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 788.00 Cr.. The value appears to be declining and may need further review. It has decreased from 806.00 Cr. (Mar 2024) to 788.00 Cr., marking a decrease of 18.00 Cr..
• For CWIP, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 413.00 Cr.. The value appears strong and on an upward trend. It has increased from 345.00 Cr. (Mar 2024) to 413.00 Cr., marking an increase of 68.00 Cr..
• For Other Assets, as of Mar 2025, the value is 571.00 Cr.. The value appears strong and on an upward trend. It has increased from 533.00 Cr. (Mar 2024) to 571.00 Cr., marking an increase of 38.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,786.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,688.00 Cr. (Mar 2024) to 1,786.00 Cr., marking an increase of 98.00 Cr..

Notably, the Reserves (1,400.00 Cr.) exceed the Borrowings (37.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Century Enka Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 19.56. This value is within the healthy range. It has decreased from 41.34 (Mar 23) to 19.56, marking a decrease of 21.78.
• For Diluted EPS (Rs.), as of Mar 24, the value is 19.56. This value is within the healthy range. It has decreased from 41.34 (Mar 23) to 19.56, marking a decrease of 21.78.
• For Cash EPS (Rs.), as of Mar 24, the value is 44.00. This value is within the healthy range. It has decreased from 60.26 (Mar 23) to 44.00, marking a decrease of 16.26.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 624.43. It has increased from 604.90 (Mar 23) to 624.43, marking an increase of 19.53.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 624.43. It has increased from 604.90 (Mar 23) to 624.43, marking an increase of 19.53.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 798.24. It has decreased from 948.31 (Mar 23) to 798.24, marking a decrease of 150.07.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 53.22. This value is within the healthy range. It has decreased from 73.85 (Mar 23) to 53.22, marking a decrease of 20.63.
• For PBIT / Share (Rs.), as of Mar 24, the value is 30.22. This value is within the healthy range. It has decreased from 54.99 (Mar 23) to 30.22, marking a decrease of 24.77.
• For PBT / Share (Rs.), as of Mar 24, the value is 27.77. This value is within the healthy range. It has decreased from 53.91 (Mar 23) to 27.77, marking a decrease of 26.14.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 21.00. This value is within the healthy range. It has decreased from 41.39 (Mar 23) to 21.00, marking a decrease of 20.39.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 19.57. This value is within the healthy range. It has decreased from 41.34 (Mar 23) to 19.57, marking a decrease of 21.77.
• For PBDIT Margin (%), as of Mar 24, the value is 6.66. This value is below the healthy minimum of 10. It has decreased from 7.78 (Mar 23) to 6.66, marking a decrease of 1.12.
• For PBIT Margin (%), as of Mar 24, the value is 3.78. This value is below the healthy minimum of 10. It has decreased from 5.79 (Mar 23) to 3.78, marking a decrease of 2.01.
• For PBT Margin (%), as of Mar 24, the value is 3.47. This value is below the healthy minimum of 10. It has decreased from 5.68 (Mar 23) to 3.47, marking a decrease of 2.21.
• For Net Profit Margin (%), as of Mar 24, the value is 2.63. This value is below the healthy minimum of 5. It has decreased from 4.36 (Mar 23) to 2.63, marking a decrease of 1.73.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 2.45. This value is below the healthy minimum of 8. It has decreased from 4.35 (Mar 23) to 2.45, marking a decrease of 1.90.
• For Return on Networth / Equity (%), as of Mar 24, the value is 3.13. This value is below the healthy minimum of 15. It has decreased from 6.83 (Mar 23) to 3.13, marking a decrease of 3.70.
• For Return on Capital Employeed (%), as of Mar 24, the value is 4.37. This value is below the healthy minimum of 10. It has decreased from 8.16 (Mar 23) to 4.37, marking a decrease of 3.79.
• For Return On Assets (%), as of Mar 24, the value is 2.53. This value is below the healthy minimum of 5. It has decreased from 5.56 (Mar 23) to 2.53, marking a decrease of 3.03.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.03. This value is within the healthy range. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.05. It has increased from 0.00 (Mar 23) to 1.05, marking an increase of 1.05.
• For Current Ratio (X), as of Mar 24, the value is 4.57. This value exceeds the healthy maximum of 3. It has decreased from 5.43 (Mar 23) to 4.57, marking a decrease of 0.86.
• For Quick Ratio (X), as of Mar 24, the value is 3.02. This value exceeds the healthy maximum of 2. It has decreased from 3.82 (Mar 23) to 3.02, marking a decrease of 0.80.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.36. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 4.36, marking an increase of 4.36.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 51.11. This value exceeds the healthy maximum of 50. It has increased from 24.19 (Mar 23) to 51.11, marking an increase of 26.92.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 23.49. This value is within the healthy range. It has increased from 16.61 (Mar 23) to 23.49, marking an increase of 6.88.
• For Earning Retention Ratio (%), as of Mar 24, the value is 48.89. This value is within the healthy range. It has decreased from 75.81 (Mar 23) to 48.89, marking a decrease of 26.92.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 76.51. This value exceeds the healthy maximum of 70. It has decreased from 83.39 (Mar 23) to 76.51, marking a decrease of 6.88.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 21.73. This value is within the healthy range. It has decreased from 68.67 (Mar 23) to 21.73, marking a decrease of 46.94.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 9.58. This value is within the healthy range. It has decreased from 39.49 (Mar 23) to 9.58, marking a decrease of 29.91.
• For Enterprise Value (Cr.), as of Mar 24, the value is 921.42. It has increased from 799.07 (Mar 23) to 921.42, marking an increase of 122.35.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.52. This value is below the healthy minimum of 1. It has increased from 0.38 (Mar 23) to 0.52, marking an increase of 0.14.
• For EV / EBITDA (X), as of Mar 24, the value is 7.92. This value is within the healthy range. It has increased from 4.95 (Mar 23) to 7.92, marking an increase of 2.97.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.50. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 23) to 0.50, marking an increase of 0.14.
• For Retention Ratios (%), as of Mar 24, the value is 48.88. This value is within the healthy range. It has decreased from 75.80 (Mar 23) to 48.88, marking a decrease of 26.92.
• For Price / BV (X), as of Mar 24, the value is 0.64. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 23) to 0.64, marking an increase of 0.08.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.50. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 23) to 0.50, marking an increase of 0.14.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 23) to 0.04, marking a decrease of 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness